Performed in Thailand, the phase 2a trial of its drug BIT225 with conventional treatment showed that 87 per cent of those who used the drug had undetectable levels of the virus in their blood after three months.
That is a significant advance on conventional anti-viral treatment alone and holds out hopes that a new combination treatment could one day completely rid the body of a Hep C infection.
Read more.....
0 comments:
Post a Comment